Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.3
-457.78%
40%
—
-48.19%
20%
—
5 Years
Score2.3
Net Growth-457.78%
Net Trend40%
Net Income Consistency—
Rev Growth-48.19%
Rev Trend20%
Revenue Consistency—
Trinity Biotech plc fundamental performance
Between 2004 and 2024, revenue declined from $ 79M to $ 61M and net income went from $ 5M to -$ 31M. Revenue increased in 7 of those 20 years; net income in 9.
Across Trinity Biotech plc's full reported history, from 1995 to 2024, revenue grew from $ 9M to $ 61M and net income went from -$ 800K to -$ 31M. Revenue increased in 53% of the years measured; net income in 50%.
Trinity Biotech plc currently holds a 20-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 11.65 | — |
5 Years2021-08-12 | $ 11.35 | 2.64% |
10 Years2016-08-12 | $ 62.70 | -81.42% |
20 Years2006-08-11 | $ 6.99 | 66.63% |
30 Years1996-08-12 | $ 14.77 | -21.11% |
All Time1995-08-18 | $ 8.38 | 39.09% |
| Period | Last Price2026-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1995-08-18 |
|---|---|---|---|---|---|---|
| Price | $ 11.65 | $ 11.35 | $ 62.70 | $ 6.99 | $ 14.77 | $ 8.38 |
| Return | — | 2.64% | -81.42% | 66.63% | -21.11% | 39.09% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 52M | -$ 35M | $ 1M |
| 2024 | $ 61M | -$ 31M | $ 5M |
| 2023 | $ 56M | -$ 24M | $ 3M |
| 2022 | $ 62M | -$ 41M | $ 6M |
| 2021 | $ 81M | $ 875K | $ 25M |
| 2020 | $ 101M | -$ 6M | $ 27M |
| 2019 | $ 90M | -$ 4M | $ 16M |
| 2018 | $ 97M | $ 2M | $ 30M |
| 2017 | $ 99M | -$ 40M | $ 57M |
| 2016 | $ 99M | -$ 100M | $ 77M |
| 2015 | $ 100M | $ 21M | $ 101M |
| 2014 | $ 104M | $ 17M | $ 9M |
| 2013 | $ 91M | $ 10M | $ 22M |
| 2012 | $ 82M | $ 17M | $ 74M |
| 2011 | $ 77M | $ 15M | $ 71M |
| 2010 | $ 89M | $ 60M | $ 58M |
| 2009 | $ 125M | $ 11M | $ 6M |
| 2008 | $ 140M | -$ 77M | $ 5M |
| 2007 | $ 143M | -$ 35M | $ 8M |
| 2006 | $ 118M | $ 3M | $ 2M |
| 2005 | $ 98M | $ 5M | $ 9M |
| 2004 | $ 79M | $ 5M | $ 22M |
| 2003 | $ 65M | $ 5M | $ 20M |
| 2002 | $ 51M | $ 5M | $ 5M |
| 2001 | $ 37M | $ 1M | $ 5M |
| 2000 | $ 29M | $ 4M | $ 4M |
| 1999 | $ 26M | $ 4M | $ 3M |
| 1998 | $ 23M | $ 2M | $ 1M |
| 1997 | $ 16M | $ 1M | $ 2M |
| 1996 | $ 7M | -$ 900K | $ 4M |
| IPO1995 | $ 9M | -$ 800K | $ 7M |
Explore beyond TRIB
You're looking at Trinity Biotech plc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
